AstraZeneca is working with partners to use data and evidence to identify underserved communities and target prevention, earlier diagnosis and treatment for lung health
Public source
Publisher name
Public post
Did you know that people in the lowest socioeconomic groups could face a ~50–80% greater risk of developing lung cancer than those in the highest? And for COPD, they cou…
Company
AstraZeneca
- Industry
- Pharmaceutical Manufacturing
- Location
- Cambridge, GB
- Company size
- 10,001+ employees
About AstraZeneca
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
See moreLatest activity
Latest activity from AstraZeneca
141 signals
Presence & Recognition
AstraZeneca leaders share their vision for how continued scientific progress could transform what is possible by 2040 as they head into WCLC 2026
Presence & Recognition
AstraZeneca is reflecting on the future of lung cancer care ahead of WCLC 2026.
Research & Knowledge
AstraZeneca and partner Amgen announced positive high-level Phase III results from the DeLLphi-305 trial in extensive-stage small cell lung cancer.
Discover more
Similar signals
Similar public activity from other companies.
Partnerships
Novartis
Novartis and The Max Foundation have partnered for 25 years to help ensure cancer care breakthroughs reach more patients around the world.
Partnerships
J&J Innovative Medicine Europe, Middle East & Africa (EMEA)
J&J Innovative Medicine Europe, Middle East & Africa (EMEA) partnered with CLL Advocates Network to champion advocacy, support, and scientific advancements.
Partnerships
Boehringer Ingelheim
Boehringer Ingelheim is working with Owkin to access and generate multimodal patient data to improve disease biology understanding and support data-driven discovery across oncology and immunology.
Partnerships
Daiichi Sankyo España